Ledger.Open graph →
SEC Form D · filed January 6, 2017

AILERON THERAPEUTICS INC

Offering
$40.0M
Sold
$30.1M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
CAMBRIDGE, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (20)

Brian M. Gallagher, Jr · Cambridge, MADirectorJohn H. Mcarthur · Cambridge, MADirectorJoseph A. Yanchik Iii · Cambridge, MAExec · DirectorReinhard J. Ambros · Cambridge, MADirectorArmen H. Shanafelt · Cambridge, MADirectorSeth L. Harrison · Cambridge, MADirectorScott L. Kapnick · Cambridge, MADirectorChristina Yeung · San Francisco, CADirectorDhruvkaran Mehta · San Francisco, CAExec · DirectorManuel H. Aivado · Cambridge, MAExecCaleb H. Winder · Cambridge, MADirectorJoshua Weissburg · San Francisco, CAExec · DirectorFox Point Capital Management LLC · New York, NYDirectorFox Point Performance LP · New York, NYDirectorShober Holdings LLC · New York, NYDirectorBill Burgess · Chicago, ILDirectorGreg Buchholz · Chicago, ILDirectorChuck Teubner · Chicago, ILDirectorManuel H. Aivado · Cambridge, MAExecCaleb H. Winder · Cambridge, MADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗